Induction Therapy

The first phase of AML treatment is known as the remission induction phase. Its aim is to destroy AML cells and restore normal blood cell production. Remission is achieved when there is no visible evidence of AML cells in the blood or bone marrow, and normal numbers of healthy blood cells are present. Depending on the type of AML you have, you may receive combination chemotherapy, high- or low-dose chemotherapy.

You are likely to spend most of your time receiving induction therapy in hospital because of the need for antibiotics and frequent transfusions. Treatment usually takes around 4 to 6 weeks. Some patients will need more than one course of induction therapy to achieve remission.



Co to jest leczenie indukujace?

Dr Agnieszka Wierzbowska z Uniwersytetu Medycznego w Lodzi tlumaczy, na czym polega leczenie indukujace. Jest to pierwszy etap leczenia majacy na celu eliminacje wiekszosci komórek nowotworowych ze szpiku kostnego.


El tratamiento de inducción

Nos lo explica la doctora Anna Sureda, Jefa del Servicio de Hematología del Hospital Duran i Reynals (Instituto Catalán de Oncología), en una entrevista realizada en el congreso de la Sociedad Americana de Hematología (ASH) en diciembre de 2016.


La terapia di induzione

La dott.ssa Chiara Bonini, docente all’Università Vita-Salute San Raffaele di Milano (IT), al Congresso Annuale dell’ASH (American Society of Hematology) del 2016 definisce la terapia di induzione come possibilità per il paziente di passare dalla fase di diagnosi della malattia alla fase in cui la malattia può arrivare fino a una remissione completa.


Terapia de indução em leucemias agudas

Neste vídeo, o Dr. Eduardo Rego da Universidade de São Paulo, São Paulo, Brasil, descreve a terapia de indução.


Join Our Community Register for Events Read Our Latest Blog

Page last updated on April 3, 2017